
Why the Coronavirus Slipped Past Disease Detectives
Groups of scientists tasked with identifying pandemic-prone microbes were stretched too far and thin
Charles Schmidt has written for Undark, Nature, Science, NPR and the Washington Post, among many other publications.

Why the Coronavirus Slipped Past Disease Detectives
Groups of scientists tasked with identifying pandemic-prone microbes were stretched too far and thin

Phage Therapy Could Beat Drug-Resistant Illnesses
Treatment first used in the early 20th century is showing promise against deadly infections

New Elevation Measure Shows Climate Change Could Quickly Swamp the Mekong Delta
A surprise revelation means 12 million Vietnamese may need to retreat

Cyberchondriacs Just Know They Must Be Sick
Researchers are unraveling the psychological reasons why some people relentlessly self-diagnose themselves online for hours a day

New Studies Link Cell Phone Radiation with Cancer in Male Rats
Researchers call for greater caution, but skeptics say the evidence from rat studies is not convincing

Many Pediatric Studies Are a Waste of Time
New initiatives aim to lessen the obstacles to finding useful treatments for children

Scientists Struggle to Determine Risky Levels of PFCs in Drinking Water
More communities are emerging as hotspots for drinking water tainted with PFCs, but scientists and regulators are struggling to determine how much is unsafe

Why the FDA Wants More Control over Some Lab Tests
The FDA finds that many so-called laboratory-derived tests may actually harm patients

Is Agent Orange Still Causing Birth Defects?
Vietnam insists that children are suffering today from the lingering effects of the infamous defoliant sprayed by U.S. forces decades ago. Scientists are undecided

For the First Time Chemists Measure the Energy of a Chemical Reaction's Transition State
The ability to quantify the elusive moment when entities in a reaction convert “is important wherever chemistry is important,” researchers say

Mental Health May Depend on Creatures in the Gut
The microbiome may yield a new class of psychobiotics for the treatment of anxiety, depression and other mood disorders